These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2884417)

  • 21. Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine.
    Fischer C; Maier K; Klotz U
    J Chromatogr; 1981 Oct; 225(2):498-503. PubMed ID: 6117565
    [No Abstract]   [Full Text] [Related]  

  • 22. Will there be a next generation of sulfasalazine?
    Goldman P
    Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of treatment for ulcerative colitis.
    Steinberg H
    JAMA; 1998 Aug; 280(5):422. PubMed ID: 9701075
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current medical treatment of hemorrhagic rectocolitis].
    Gendre JP
    Gastroenterol Clin Biol; 1994; 18(2 Pt 3):T9-12. PubMed ID: 7913901
    [No Abstract]   [Full Text] [Related]  

  • 25. Sulphasalazine-induced reversible male infertility.
    Delaere KP; Strijbos WE; Meuleman EJ
    Acta Urol Belg; 1989; 57(1):29-33. PubMed ID: 2566274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H
    Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM; Greenberg GR
    Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ
    Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disodium azodisalicylate. American College of Gastroenterology Committee on FDA-Related Matters.
    Levinson RA
    Am J Gastroenterol; 1985 Mar; 80(3):203-5. PubMed ID: 2858154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Conservative therapy of ulcerative colitis--long-term experience].
    Kölbel C; Goebell H
    Internist (Berl); 1991 Sep; 32(9):530-9. PubMed ID: 1683664
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
    Lauritsen K
    Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
    [No Abstract]   [Full Text] [Related]  

  • 33. Sulphasalazine in ulcerative colitis.
    Michalowski AS
    Gut; 1992 Nov; 33(11):1582. PubMed ID: 1360440
    [No Abstract]   [Full Text] [Related]  

  • 34. Reversal of male infertility on changing treatment from sulphasalazine to 5-aminosalicylic acid.
    Cann PA; Holdsworth CD
    Lancet; 1984 May; 1(8386):1119. PubMed ID: 6144844
    [No Abstract]   [Full Text] [Related]  

  • 35. [Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
    Maier KP
    Dtsch Med Wochenschr; 1992 Oct; 117(42):1614-5. PubMed ID: 1356747
    [No Abstract]   [Full Text] [Related]  

  • 36. Olsalazine in patients intolerant of sulphasalazine.
    Ireland A; Jewell DP
    Scand J Gastroenterol; 1987 Nov; 22(9):1038-40. PubMed ID: 2892247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL
    Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Aminosalicylic acid in patients with an ileo-rectal anastomosis. A comparison of the fate of sulfasalazine and Pentasa.
    Bondesen S; Tage-Jensen U; Jacobsen O; Hansen SH; Rasmussen SN; Hvidberg EF
    Eur J Clin Pharmacol; 1986; 31(1):23-6. PubMed ID: 2877884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW; Gales BJ
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.